Form 4: DexCom Executive Sadie Stern Adjusts Holdings

Sadie Stern, EVP Chief People & Culture Officer at DexCom Inc., reported a transaction involving common stock, with shares withheld for tax obligations.

Summary

• Sadie Stern, Executive Vice President and Chief People & Culture Officer of DexCom Inc., engaged in a transaction on May 22, 2026.
• 1,451 shares of common stock were involved, with a transaction code 'F' indicating a disposition.
• The transaction price was $71.9 per share.
• These shares were withheld by the issuer to cover tax withholding and remittance obligations related to the net settlement of restricted stock units.
• Following this transaction, Stern beneficially owns 130,059 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard tax withholding event for equity compensation and does not reflect a change in beneficial ownership or executive sentiment towards the company's stock.

Positives

• The transaction was a tax withholding event, not a sale of shares by the reporting person, indicating continued equity ownership.
• Sadie Stern continues to hold a significant number of shares (130,059) directly.

Negatives

• A disposition of 1,451 shares occurred, although it was for tax withholding purposes.

Future Outlook

The filing details the vesting schedule for existing restricted stock units, with grants from March 2024, March 2025, and March 2026 vesting through March 2027, March 2028, and March 2029, respectively. No new forward-looking financial guidance is provided.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. This particular filing indicates a routine tax settlement for restricted stock units, which is common for executives receiving equity compensation. It does not signal a change in the executive's confidence in the company's future performance.

Stakeholder Impact

• Shareholders: No direct impact as this is a tax-related event and not a sale of shares by the executive.
• Employees: This filing is a routine disclosure and does not directly impact other employees.
• Management: Reflects standard executive compensation practices.

Next Steps

• Vesting of remaining restricted stock units according to their respective schedules (through March 2027, 2028, and 2029).

Key Dates

Keywords

SEC Form 4, DexCom Inc., DXCM, Sadie Stern, Beneficial Ownership, Stock Transaction, Restricted Stock Units, Tax Withholding